the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Conditions

Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)

Keywords

Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension, balloon pulmonary angioplasty, cardiopulmonary exercise test

Brief summary

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Detailed description

patients diagnosed with pulmonary hypertension, including pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, will be evaluated by cardio pulmonary exercise test before and after medical or balloon pulmonary angioplasty treatment

Xin Li, Anqi Duan, Qi Jin, Yi Zhang, Qin Luo et al. (12 authors)

ESC Heart Failure2022-09-132 citations

10.1002/ehf2.14154

Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.

Tang Y, Yao L, Liu Z, Ma X, Luo Q, Zhao Z, Huang Z, Tu L, Gao L, Jin Q, Ni X, Xiong C.

2017-02-015 citations

10.1016/j.pupt.2017.01.012

Abstract 13929: Cardiopulmonary Fitness Index a Novel Index That Improves Prognostic Assessment of Patients With Idiopathic Pulmonary Arterial Hypertension

Yi Tang, Qin Luo, Zhihui Zhao, Liu Gao, Qi Jin et al. (7 authors)

Circulation2016-11-11

10.1161/circ.134.suppl_1.13929

Interventions

DEVICEballoon pulmonary angioplasty

patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

5 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

* pulmonary arterial hypertension;( WHO1) * chronic thromboembolic pulmonary hypertension; * pulmonary arterial hypertension due to other cause;

Exclusion criteria

* massive hemoptysis; * unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders; * recent recurrent syncope; * pulmonary hypertension due to hypoxia; * pulmonary hypertension due to left heart diseases.

Design outcomes

Primary

Measure	Time frame	Description
all cause mortality	5 years	all cause mortality
mean pulmonary arterial pressure after treatment	5 years	the mean pulmonary arterial pressure of patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty treatment
achievement of low risk	5 years	patients with chronic thromboembolic pulmonary hypertension achievement of low risk after balloon pulmonary angioplasty

Secondary

Measure	Time frame	Description
deterioration of WHO function	5 years	deterioration of WHO function

Countries

China

Contacts

Primary ContactZhihong Liu, Doctor

zhihongliufuwai@163.com8601088396590

Outcome results

None listed